About STAPGEN LLC
Stapgen is a company focused on pioneering preventive care for chronic inflammatory diseases, particularly Type 2 Diabetes, through gut-health technology. The company develops diagnostics and therapeutics centered around intestinal alkaline phosphatase (IAP) deficiency.
Development of STAP-Test to detect intestinal alkaline phosphatase (IAP) levels in stool samplesCreation of supplements to prevent Type 2 Diabetes (T2DM)Development of IAP-Toothpaste to prevent infant dental cariesResearch and development in the prevention and cure of Type 2 DiabetesResearch in the areas of Dementia, Diabetes, Colorectal cancer, and Coronary artery disease
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to STAPGEN LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.